Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Grants to USA, Canada, and International Researchers for Epilepsy-Related Studies

ELIGIBILITY:

Geographic Focus

USA: AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew York CityNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashington, DCWashingtonWest VirginiaWisconsinWyoming

USA Territories: American Samoa (USA)Guam (USA)Puerto Rico (USA)Virgin Islands (USA)Northern Mariana Islands (USA)

USA Compact Free Associations: The Federated States of Micronesia (USA)  Marshall Islands (USA)  Republic of Palau (USA)

Canada: AlbertaBritish ColumbiaManitobaNew BrunswickNewfoundland and LabradorNorthwest TerritoriesNova ScotiaNunavutOntarioPrince Edward IslandQuebecSaskatchewanYukon

GrantRegions Object ( [regions] => Array ( ) [is_initialized] => [error_messages] => Array ( ) [qm] => QueryManager Object ( [is_debug] => [conn] => mysqli Object ( [affected_rows] => 9 [client_info] => mysqlnd 5.0.12-dev - 20150407 - $Id: 3591daad22de08524295e1bd073aceeff11e6579 $ [client_version] => 50012 [connect_errno] => 0 [connect_error] => [errno] => 0 [error] => [error_list] => Array ( ) [field_count] => 2 [host_info] => 172.16.38.157 via TCP/IP [info] => [insert_id] => 0 [server_info] => 5.5.5-10.5.18-MariaDB [server_version] => 100518 [stat] => Uptime: 3107157 Threads: 256 Questions: 531386942 Slow queries: 1306 Opens: 118375 Open tables: 415 Queries per second avg: 171.020 [sqlstate] => 00000 [protocol_version] => 10 [thread_id] => 86261449 [warning_count] => 0 ) ) [has_regions] => 1 [state_names] => Array ( [0] => Alabama; [1] => Alaska; [2] => Arizona; [3] => Arkansas; [4] => California; [5] => Colorado; [6] => Connecticut; [7] => Delaware; [8] => Florida; [9] => Georgia; [10] => Hawaii; [11] => Idaho; [12] => Illinois; [13] => Indiana; [14] => Iowa; [15] => Kansas; [16] => Kentucky; [17] => Louisiana; [18] => Maine; [19] => Maryland; [20] => Massachusetts; [21] => Michigan; [22] => Minnesota; [23] => Mississippi; [24] => Missouri; [25] => Montana; [26] => Nebraska; [27] => Nevada; [28] => New Hampshire; [29] => New Jersey; [30] => New Mexico; [31] => New York; [32] => North Carolina; [33] => North Dakota; [34] => New York City; [35] => Ohio; [36] => Oklahoma; [37] => Oregon; [38] => Pennsylvania; [39] => Rhode Island; [40] => South Carolina; [41] => South Dakota; [42] => Tennessee; [43] => Texas; [44] => Utah; [45] => Vermont; [46] => Virginia; [47] => Washington; [48] => Washington, DC; [49] => West Virginia; [50] => Wisconsin; [51] => Wyoming; ) [province_names] => Array ( [0] => Alberta; [1] => British Columbia; [2] => Manitoba; [3] => New Brunswick; [4] => Newfoundland and Labrador; [5] => Northwest Territories; [6] => Nova Scotia; [7] => Nunavut; [8] => Ontario; [9] => Prince Edward Island; [10] => Quebec; [11] => Saskatchewan; [12] => Yukon; ) [country_names] => Array ( [1] => American Samoa (USA) [2] => The Federated States of Micronesia (USA) [3] => Guam (USA) [4] => Marshall Islands (USA) [5] => Puerto Rico (USA) [6] => Republic of Palau (USA) [7] => Virgin Islands (USA) [8] => Northern Mariana Islands (USA) ) [is_israel] => 1 [territories] => Array ( [0] => American Samoa (USA); [1] => Guam (USA); [2] => Puerto Rico (USA); [3] => Virgin Islands (USA); [4] => Northern Mariana Islands (USA); ) [free_associations] => Array ( [0] => The Federated States of Micronesia (USA) [1] => Marshall Islands (USA) [2] => Republic of Palau (USA) ) )

Israel

International country outside of the USA, Israel and Canada.

CURE Taking Flight Award

Citizens United for Research in Epilepsy (CURE)


Agency: Foundation

GrantWatch ID #178500

Grant Description

Grants to USA, Canada, and International researchers for projects related to epilepsy prevention, therapy, and treatments. Applicants must submit a letter of intent prior to applying. The goal of the program is to encourage young researchers to develop independent studies that are distinct from that of their mentors.

Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Applicants will be required to discuss how this avenue of research is independent of their mentor’s research and will lead them to a path of independent epilepsy research. Studies that will provide new directions for epilepsy therapy, prevention, and, ultimately, a cure and that will allow applicants to collect the data necessary to support a grant application to the National Institutes of Health or a similar granting agency are encouraged. 

CURE Epilepsy encourages applications from groups underrepresented in the biomedical, clinical, behavioral, and social sciences. These groups include individuals with disabilities, veterans, persons from underrepresented racial and ethnic groups and gender-diverse groups, women in biomedical-related disciplines, or any legally protected characteristic.

Priority Areas

CURE Epilepsy’s priority research areas focus on those that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with CURE Epilepsy's mission. 

  • Transformative research to enhance understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
  • Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy. Examples include epilepsy that develops after stroke, tumor, traumatic brain injury or infection, including febrile infection-related epilepsy syndrome (FIRES) as well as new-onset refractory status-epilepticus (NORSE)
  • Research that will inform the development of novel therapies to prevent onset or halt the progression of severe pediatric epilepsies
  • Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
  • Novel research that furthers understanding of the causes and ultimate elimination of SUDEP
  • Translational, clinical, and clinically informed basic research that will facilitate understanding of the cellular-, molecular-, and systems-level mechanisms that underlie the relationships between sleep and epilepsy

Funding requests may include salary support for the Principal Investigator (PI), technical staff, supplies necessary to perform the work, animal costs, publication fees, and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research. 

For additional information on eligible costs, see: https://www.cureepilepsy.org/wp-content/uploads/2022/10/2023-Taking-Flight-Award-LOI-Full-Propsal-Guidelines.pdf#page=11

Need help writing this grant?

Eligibility:

  • Others (see text field entitled "Additional Eligibility Criteria" for clarification)

Additional Eligibility Criteria:

Applicants must generally fall into one of the following categories to be eligible for the Taking Flight Award:
- A senior postdoctoral fellow who has a minimum of 3 years postdoctoral experience.
- A researcher with an appointment as an Instructor or Research Assistant Professor who has yet to obtain significant funding (e.g., RO1 grant or equivalent) and has an on-site mentor committed to advising the applicant.
- A faculty member at the assistant professor level who is within one year of having been appointed.
- A clinical fellow who is pursuing a residency in the following areas: neurology, neurosurgery or neurocritical care, and considering an epilepsy-focused fellowship.

International applicants are welcome; you do not have to be a US citizen or working in the US to apply for this award.

Researchers who have already received significant funding (e.g., NIH K99 award or equivalent) are not eligible for CURE Epilepsy funding.

Based on CURE Epilepsy’s current research objectives, lower priority will be given for research in the following areas:
- Research that focuses solely on a comorbid condition without also seeking to address/understand the accompanying epilepsy
- Research that focuses solely on improving localization of the epileptic seizure focus

Funds are not to be used to purchase equipment. Indirect costs are not supported.

Funds cannot be used to cover institutional expenses such as network charges, computer maintenance and services, insurance dues or other miscellaneous expenses not directly related to performing the project.

Pre-Application Information:

Key Dates:
- Request for Proposals Opens: Wednesday, November 30, 2022
- Letter of Intent Deadline: Tuesday, January 10, 2023 – 9pm ET
- Full Application Invitations: Friday, February 17, 2023
- Full Application Deadline: Tuesday, March 28, 2023 – 9pm ET
- Anticipated Award Announcement: July 2023
- Anticipated Project Start Date: September 2023

All applicants must submit a Letter of Intent (LOI). Following review of LOIs, select applicants will be invited to submit full proposals.

All materials must be submitted in English.

There is no limit to the number of researchers from the same institution who can apply for the same grant.

FAQs: https://www.cureepilepsy.org/for-researchers/grant-faqs/
Grant Process: https://www.cureepilepsy.org/grants-program/#grant_process

For additional relevant links, see URL for Full Text (RFP) link, below.

Additional Funding Information:

Estimated Size of Grant:

Requests may be made for up to $100,000.

Term of Contract:

- One year
- Anticipated Project Start Date: September 2023
- CURE Epilepsy does not provide deadline extensions.

Contact Information:

Apply online: https://proposalcentral.com/

Questions regarding these guidelines are welcome and should be directed to the Research Team at Research@CUREepilepsy.org or 312-255-1801.

CURE
420 N. Wabash Avenue, Suite 650
Chicago, IL 60611

Mailing address:
PO Box 10572
Chicago, IL 60610

Live Chat Chat Now